Search Contact
Click here to schedule a meeting
with our Business Development team
at Vitafoods Asia 2019.

Learn more about our probiotics
with exclusive mechanisms of action

Discover our
clinical research

Neuropharmagen is a precision medicine
tool especially developed for psychiatry

The Board of Directors calls for an Extraordinary Shareholders Meeting to be held on October 4th
The Board of Directors of AB-Biotics calls for an Extraordinary Shareholders Meeting to be held on October 4th at the Barcelona Stock Exchange to approve the...
Read More
Kaneka has successfully completed its voluntary takeover bid and taken control of AB-Biotics, holding 66.33% of its capital
AB-Biotics has informed the CNMV that Kaneka Europe Holding has successfully completed the voluntary takeover bid for the 60.24% (7.583.025) of the company it did not...
Read More
The Board of Directors request a fairness opinion about the price offered by Kaneka
At a meeting held yesterday, the Board of Directors of the Company has adopted, unanimously (the directors designated by Kaneka Europe Holding Company NV –“Kaneka” abstaining from participating), among others, the following decisions:   These directors appreciate that the offer formulated by Kaneka entails a commitment with the Company’s entrepreneurial   In compliance with its duties of diligence, request a fairness opinion from one of the...
Read More
About ab-biotics
Research in its own
collection of more than
1.000 strains of
probiotic bacteria
Development of
advanced genetic tools
for pharmacogenetics
Precision medicine